Neurocutaneous Melanocytosis Registry
Recruiting
Observational Study
Cutaneous Melanocytic Neoplasm
Large Cutaneous Melanocytic Nevi
Neurocutaneous Melanocytosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study will involve collecting information about the regular medical care you receive for large cutaneous melanocytic nevi (LCMN) or neurocutaneous melanocytosis (NCM).
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with LCMN, defined as:
* Dark-colored patch of skin present at birth
* Can be located anywhere on the individual's skin
* May include satellite lesions
* May be associated with hypertrichosis
OR, in absence of cutaneous involvement:
* histologically or radi…
Contacts